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ABSTRACT
Background Patients with trauma are at risk for renal
dysfunction from hypovolemia or urological injury. In
austere environments, creatinine values are not available
to guide resuscitation. A new portable device, the Stat
Sensor Point-of-care (POC) Whole Blood Creatinine
Analyzer, provides accurate results in <30 s and requires
minimal training. This device has not been evaluated in
trauma despite the theoretical benefit it provides. The
purpose of this study is to determine the clinical impact
of the POC device in trauma.
Methods 40 patients with trauma were enrolled in a
prospective observational study. One drop of blood was
used for creatinine determination on the Statsensor POC
device. POC creatinine results were compared to the
laboratory. Turnaround time (TAT) for POC and
laboratory methods was calculated as well as time
elapsed to CT scan if applicable.
Results Patients (n=40) were enrolled between
December 2014 and March 2015. POC creatinine values
were similar to laboratory methods with a mean bias of
0.075±0.27 (p=0.08). Mean analytical TATs for the
POC measurements were significantly faster than the
laboratory method (11.6±10.0 min vs 78.1±27.9 min,
n=40, p<0.0001). Mean elapsed time before arrival at
the CT scanner was 52.9±34.2 min.
Conclusions The POC device reported similar
creatinine values to the laboratory and provided
significantly faster results. POC creatinine testing is a
promising development for trauma practice in austere
environments and workup of a subset of stable patients
with trauma. Further study is warranted to determine
clinical impact, both in hospital-based trauma and
austere environments.
INTRODUCTION
Trauma patients are at risk for renal dysfunction
from hypovolemia or urological injury. In austere
environments, however, creatinine values are typic-
ally not available to guide resuscitation. A new
portable device, the Stat Sensor Point-of-care
(POC) Whole Blood Creatinine Analyzer (Nova
Biomedical, Waltham, Massachusetts, USA), has
been evaluated in other fields, including monitoring
resuscitation in burn surgery,1 2 trending post-
operative renal function in patients with renal
transplant,3 and in radiology departments to screen
for renal failure prior to contrast administration.4 It
provides accurate results4–6 in <30 s and requires
minimal training. This device has not been evalu-
ated in the trauma setting despite the theoretical
benefit it provides. This device can potentially be
used for rapid creatinine results in austere
environments7 that historically do not have access
to renal function tests.
The purpose of this study is to determine the
potential clinical impact of this POC creatinine ana-
lyzer in the trauma setting. Our hypothesis is that
the POC creatinine device can be integrated into
the existing trauma system and will result creatinine
values similar to the hospital laboratory, but signifi-
cantly faster.
METHODS
The present study was approved by the Institutional
Review Board. We performed a prospective observa-
tional study of adult patients who came into the
emergency room at a single Level I trauma center
coded as major traumas, based on prehospital triage
criteria. Prisoners, pediatric patients (<18 years
old), and pregnant women were excluded. Patients
were also excluded if their planned workup did not
include creatinine testing. Enrollment occurred
between 6:00 and 18:00, on weekdays between
January and April of 2015, in a population of con-
venience. The primary outcome was POC creatinine
level, compared to the laboratory value. The sec-
ondary outcomes were turnaround time (TAT) of
the POC and laboratory creatinine levels and the
time elapsed for the patient to arrive at the CT
scanner, when applicable.
For each enrolled patient, a single drop of blood
was taken from the same initial sample as the
patient’s other laboratory tests. The blood sample
was tested using the POC whole blood creatinine
meter. The creatinine value, the time it was
obtained, and the patient’s arrival time were
recorded. The creatinine and time information was
not provided to the managing trauma team and did
not impact clinical decisions. Informed consent was
obtained within 24 hours of arrival, prior to
further data abstraction from the medical record.
The electronic medical record was used to obtain
the laboratory creatinine value, the time it became
available, and the time the patient arrived at the
CT scanner, when applicable. POC creatinine
results were compared directly to the laboratory
value. TATs for POC and laboratory methods were
calculated as well as time elapsed to CT scan when
applicable. Creatinine values and TATs were calcu-
lated using a standard t-test.
RESULTS
Forty patients were enrolled between December
2014 and March 2015. The mean age was
71.2 years. Thirty per cent were women.
Ninety-five per cent had sustained blunt trauma
and 20% required operative management. The
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median hospital length of stay was 2 days. The median injury
severity score was 4 (range 0–36). Please see table 1 for
demographics.
Mean POC creatinine values were 1.01±0.33, compared to
1.08±0.34 for laboratory creatinine. The difference between
these values was not statistically significant, with a mean bias or
difference between POC and laboratory values, of 0.075±0.27
(p=0.08). Figure 1 is a Bland-Altman Plot, which shows the
laboratory creatinine value on the x axis and the bias on the y
axis. Figure 2 plots laboratory creatinine on the x-axis and POC
creatinine on the y-axis.
Mean analytical TATs for the POC measurements were signifi-
cantly faster than the laboratory method (11.6±10.0 min vs
78.1±27.9 min, p<0.0001). The mean elapsed time before
arrival at the CT scanner for the 30 patients who underwent CT
imaging was 52.9±34.2 min. At the time of CT scanning, 29 of
30 had POC creatinine values available, while only 5 of 30 had
laboratory creatinine values available. Please see table 2 for
these results.
DISCUSSION
The purpose of this prospective observational study is to deter-
mine the potential clinical impact of this POC creatinine ana-
lyzer in the trauma setting. While its accuracy was known in
other settings, it was important to know if the device could be
used in a practical manner in the trauma setting. We had three
key findings: the device provided accurate creatinine values, the
information was available rapidly, typically before contrast was
administered for imaging, and it was successfully implemented
in our trauma workflow. The study supported the hypothesis
that the POC creatinine device can be integrated into the exist-
ing trauma system and will result in creatinine values similar to
the hospital laboratory, but significantly faster. The strength of
this study is that it demonstrates prospectively that the device is
functional in the trauma setting. The study design was chosen
since the use of this device has not been established in trauma.
This study has several limitations. As a small, prospective
observational study, it does not evaluate a specific intervention;
neither does it influence the situations in which this device
should be used. Further study is needed to determine if obtain-
ing creatinine values truly impacts management in the practical
setting, as well as to evaluate the short-term and long-term out-
comes of using this information to tailor workup and manage-
ment of individual patients.
Table 1 Demographics
Mean age 71.2 years
Gender 30% women
Type of trauma 95% blunt, 5% penetrating
Median hospital length of stay 2 days
Patients who underwent operative management 20%
Median injury severity score 4
Figure 1 Bland-Altman plot. POC,
point-of care.
Figure 2 POC versus laboratory
creatinine. POC, point-of care.
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On initial observation, the p value of 0.08 for the difference
between POC and laboratory creatinine values is close to our
predefined cutoff of 0.05, suggesting that there is a chance there
would be a statistically significant difference if a larger sample
was evaluated. Despite this, the absolute difference, or bias, of
0.07 is low and is the more critical value to evaluate in labora-
tory medicine. This tells us that even if there is a systematic dif-
ference between the values that is due to more than chance, it is
small enough to not be clinically significant. This could be
assessed further with a larger study. The difference in values
may be explained by the difference in biochemical reactions as
the POC device uses electrochemistry to test whole blood and
the laboratory uses the kinetic Jaffe reaction on plasma.
The vast majority of patients in this study had normal creatin-
ine values. Therefore, while the data support the accuracy of the
creatinine values for patients with normal creatinine, the accur-
acy outside of the normal range was not demonstrated. A larger
study or a different patient population would be necessary to
look at the device in patients with renal failure.
This device may affect practice in austere environments,
where determination of creatinine values with a small,
inexpensive device could prove beneficial. There is a precedent
for POC creatinine determination in an austere environment;7
more research would be needed to determine its role in the care
of trauma and surgical patients. Potential uses include resuscita-
tion and management during prolonged transport and manage-
ment of perioperative patients without access to a full
laboratory. Forward surgical teams in role II settings may benefit
by having an easily portable device that can be transported to
each destination. Additionally, development is underway for
similar devices that measure other important values, including
hemoglobin.
This study also has the potential to affect a subset of trauma
patients who have a low probability of critical findings on CT
scanning, but have an increased likelihood of developing
contrast-induced nephropathy. Examples of patients who may
benefit are elderly patients who sustain a ground level fall
requiring CT imaging and patients who are found down and at
risk for rhabdomyolysis. The elderly portion of the trauma
population is steadily growing, and even low energy mechanisms
can cause significant injury in these patients. If found to have
elevated creatinine, elderly patients could be resuscitated prior
to a delayed CT scan with contrast, or an algorithm could be
used to initially scan without contrast. Notably, the fact that cre-
atinine values were available prior to contrast administration in
this study means that this algorithm could potentially be imple-
mented with minimal delay of care.
Determination of creatinine values with a POC device is feas-
ible in a major trauma center. More research would be necessary
to determine its feasibility in an austere environment. The
device is quite portable; however, the test strips must be refri-
gerated in the long term.
Our outcome of obtaining similar creatinine results sooner
than laboratory values is likely reproducible in further clinical
Table 2 Creatinine data
POC
device Laboratory Difference p Value
Mean creatinine
value (mg/dL)
1.01±0.33 1.08±0.34 −0.07±0.27 (bias) 0.08
Mean time to
availability (min)
11.6±10.0 78.1±27.9 66.4±27.4 <0.0001
POC, point-of-care.
Figure 3 Example algorithm for elderly (age>60) ground-level fall patients.
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practice or research. It required no change to the structure of
our trauma service. Further research will be necessary to deter-
mine if obtaining creatinine values faster leads to improvements
in outcomes such as rate of contrast-induced nephropathy or
time markers such as time to CT scanner, time to operating
room, or time to admission.
A randomized controlled trial would be beneficial to deter-
mine if POC creatinine determination, coupled with a protocol
for managing select patients with a low energy trauma mechan-
ism, can achieve better outcomes. Please see figure 3 for a
sample algorithm for use in elderly ground level fall patients.
This device also has the potential to be used in austere envir-
onments due to its small size and inexpensive cost. Rapid deter-
mination of renal function can tailor resuscitation efforts during
extended transport, or in the field. A rigorous study to establish
feasibility can be followed by determination of the patient popu-
lations likely to benefit and the algorithms that can incorporate
rapid creatinine values. Results of the POC testing also need to
be tested in patients with profound shock and high ISS.
POC creatinine testing is a promising development for trauma
practice in austere environments and workup of a subset of
stable trauma patients with trauma. Further study is warranted
to determine the clinical impact, both hospital-based trauma
and austere environments.
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